Abstract
Aim: to establish the percentage hospital admission related to adverse drug reactions (ADRs) from the data available in the literature.Method: literature search in the Medline database, meta-analysis.Results: from the literature it is revealed that a considerable part of all hospital admissions are related to adverse drug reactions. However, these data are not homogenous, i.e. larger studies display a lower percentage of ADR related hospital admission, while smaller studies display a higher percentage. Subgroup analysis showed that for elderly people the odds of being hospitalised by ADR related problems is 4 times higher than for younger ones (16.6% vs. 4.1%). A considerable part of these hospitalisations can be prevented. Subgroup analysis revealed that in the elderly up to 88% of the ADR related hospitalisations are preventable; for the non-elderly this is only 24%. Comparatively more elderly people are hospitalised than younger ones. Combining these findings, twice as much elderly people are hospitalised by ADR related problems than non-elderly, while preventability of ADR related hospitalisation might yield 7 times more people in the elderly than in the non-elderly. The estimation of the costs of ADR related hospitalisations in the Health Care system in The Netherlands is discussed.Conclusion: many elderly people are hospitalised by ADR related problems; an important part of these hospitalisations can be avoided.
Article PDF
References
The Cochrane Library. 2000 issue 3. Update Software Ltd, Oxford, United Kingdom.
Lazarou J Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998,279:1200-5.
Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Austr 1998,168:405-8.
Allain H, Chevrant-Breton J, Beneton C, Bousser AM, Bentue-Ferrer D, Mazeas D, Driessche J van den. Consequences dermatologiques indesirables des medicaments. Resultat díune enquete pharmacovigilance. Ann Med Interne (Paris). 1983;134:530-6.
Atkin PA, Finnegan TP, Ogle SJ. Prevalence of drug related admissions to an Australian Hospital. Aust J Aging 1994;13:17-21.
Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993;8:289-94.
Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol. 1981;20:193-200.
Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991;29:989-1003.
Bigby J, Dunn J, Goldman L, Adams JB, Jen P, Landefeld CS, Komaroff AL. Assessing the preventability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care faculty. Am J Med 1987;83:1031-6.
Blackbourn J. Readmission to Fremantle Hospital. Part II. Drug related admissions. Fremantle Hosp Drug Bull 1991;15:13-6.
Caranasos GJ, Steart RB, Cluff LE. Drug-induced illness leading to hospitalization JAMA 1974;228:713-7.
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841-5.
Cooke DI, van der Merwe W, Pudifin DJ. Hospital admissions for adverse reactions to drugs and deliberate self-poisoning. S Afr Med J. 1985;67:770-2.
Cooper JW. Adverse drug reactions and interactions in a nursing home. Nurs Homes Sr Citiz Care. 1987;36:7-11.
Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J. 1999;92:485-90.
Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm. 1995; 48:161-6.
Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997;26:375-82.
Dartnell JGA, Anderson RP, ChohanV, Galbraith KJ, Lyon MEH, Nestor PJ, Mouldrs RFW. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996;1634:659-62.
Davidsen F, Haghfelt T, Gram LF, Brosen K. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol. 1988;34:83-6.
Easton KL, Parsons BJ, Starr M, Brien JE. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998;169:356-9.
Frisk PA, Cooper JW Jr, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals. Am J Hosp Pharm. 1977;34:738-42.
Galbraith K. Is there a role for a clinical pharmacist in tje emergency department? [Graduate Diploma thesis] Melbourne: Victorian College of Pharmacyt, Monash University, 1993.
Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999;33:236-40.
Gleeson CA. Adverse drug reactions causing hospital admission. [Graduate Diploma thesis]. Sydney: University of Sidney, 1988.
Guemes Artiles M, Sanz Alvarez E, Garcia Sanchez-Colomer M. Reacciones adversas y problemas relacionados con medicamentos en un servicio de urgencia. Rev Esp Salud Publica 1999;73:511-8.
Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol. 1991;26:174-80.
Hallas J, Davidsen O, Grodum E, Damsbo N, Gram LF. Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration. 1992;59:30-4.
Hallas J, Gram LE, Grodum E, Damsbo N, Brosen K, Haghfelt T, Harvald B, Beck-Nielsen J, Worm J, Jensen KB, Davidsen O, Frandsen N, Hagen C, Andersen M, Frolund M, Kromann-Andersen H, Schou J. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol. 1992;33:61-8.
Hermesh H, Shalev A, Munitz H. Contribution of adverse drug reaction to admission rates in an acute psychiatric ward. Acta Psychiatr Scand. 1985;72:104-10.
Hewitt J. Drug-related unplanned readmissions to hospital. Aust J Hosp Pharm 1995;25:400-3
Huic M, Mucolic V, Vrhovac B, Francetic I, Bakran I, Giljanovic S. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther. 1994;32:675-82.
Ibanez L, Laporte JR, Carne X. Adverse drug reactions leading to hospital admission. Drug Saf. 1991;6:450-9.
Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med. 1987;147:1117-20.
Kernan WN, Castellsague J, Perlman GD, Ostfeld A. Incidence of hospitalization for digitalis toxicity among elderly Americans. Am J Med. 1994;96:426-31.
Klein U, Klein M, Sturm H, Rothenbuhler M, Huber R, Stucki P, Gikalov I, Keller M. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int J Clin Pharmacol Biopharm. 1976;13:187-95.
Kraaij DWJ van, Haagsma CJ, Go IH, Gribnau FWJ. Diuretic use and withdrawal in patient populations. Neth J Med 1994;44:166-73.
Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med. 1986;146:1931-4.
Larmour I, Dolphin RG, Baxter H, Morrison S, Hooke DH, McGrath BP. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991;21:90-5.
Lee A, Oldenburg B. A survey of patients with cardiac disease: risk factors for admissions. Aust J Hosp Pharm 1993;23:104-8.
Leone R, Conforti A, Ghiotto E, Moretti U, Valvo E, Velo GP. Nimesulide and renal impairment. Eur J Clin Pharmacol. 1999;55:151-4.
Lepori V, Perren A, Marone C. Unerwunschte internmedizinische Arzneimittelwirkungen bei Spitaleintritt. Schweiz Med Wochenschr. 1999;129:915-22.
Levy M, Lipshitz M, Eliakim M. Hospital admissions due to adverse drug reactions. Am J Med Sci. 1979;277:49-56.
Levy M, Mermelstein L, Hemo D. Medical admissions due to noncompliance with drug therapy. Int J Clin Pharmacol Ther Toxicol. 1982; 20:600-4.
Major S, Badr S, Bahlawan L, Hassan G, Khogaoghlanian T, Khalil R, Melhem A, Richani R, Younes F, Yeretzian J, Khogali M, Sabra R. Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to selfmedicating behavior. Clin Pharmacol Ther. 1998;64:450-61.
Mannesse CK, Derkx FH, de Ridder MA, Man in ‘t Veld AJ, van der Cammen TJ: Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29:35-9.
Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Estan L, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions as a cause of admission to a paeditric hospital. Br J Clin Pharmacol. 1996;42:319-24.
McKenney JM, Harrison Wl. Drug-related hospital admissions. Am J Hosp Pharm. 1976;33:792-5.
McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm. 1973;30:898-903.
Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974;134:219-23.
Mitchel AA, Lacouture PG, Sheehan JE, Kaufman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics. 1988;82:24-9.
Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998;45:301-8.
Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701-7.
Ng D. Adverse medication-related events and unplanned admissions to an acute care general teaching hospital [Master thesis] Adelaide: University of South Australia, 1996.
Pearson TF, Pittman DG, Longley JM, Grapes T, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm. 1994 15;51:2268-72.
Perault MC, Pinelli AL, Chauveau I, Scepi M, Remblier C, Vandel B. Enquete prospective sur les admissions pour iatrogenie medicamenteuse dans le service díaccueil des urgences du centre hospitalier universitaire de Poitiers. Therapie. 1999; 54:183-5.
Popplewell PY, Henschke PJ. Acute admissions to a geriatric assessment unit. Med J Aust. 1982;1:343-4.
Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992;49:1696-700.
Salem RB, Keane TM, Williams JG. Drug-related admissions to a Veterans' Administration psychiatric unit. Drug Intell Clin Pharm. 1984;18:74-6.
Sarkawi H, Daud TM. A study of drug induced illness as a contributor to hospital admissions. Adelaide: Pharmacy Department, Royal Adelaide Hospital, 1995.
Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions, V: clinical factors influencing susceptibility. Ann Intern Med. 1966;65:629-640.
Smucker WD, Kontak JR. Adverse drug reactions causing hospital admission in an elderly population: experience with a decision algorithm. J Am Board Fam Pract. 1990;3:105-9.
Soon JA. Assessment of an adverse drug reaction monitoring program in nursing homes. Can J Hosp Pharm. 1985;38:120-5.
Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug-related admissions to an Australian hospital. J Clin Pharm Ther. 1994;19:341-7.
Stewart RB, Springer PK, Adams JE. Drug-related admissions to an inpatient psychiatric unit. Am J Psychiatry. 1980;137:1093-5.
Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: A multicentre investigation. Age Aging 1980;9:73-80.
Wong ME, Ioannides-Demos LL, Li SC, McClean AJ, Christophidis N. Drug related hospital admissions of geriatric patients. Aust J Hosp Pharm 1993;23:75.
Wu FL, Yang CC, Shen LJ, Chen CY. Adverse drug reactions in a medical ward. J Formos Med Assoc. 1996;95:241-6.
Nathan A, Goodyer L, Lovejoy A, Rashid A. ëBrown bagí medication reviews as a means of optimizing patientsí use of medication and of identifying potential clinical problems. Family Practice 1999;16:278-82.
Taras-Zazowski KM, Einarson TR. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Can J Hosp Pharm 1989;42:105-8.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
Statistical Yearbook 1999. Statistics Netherlands. Voorburg/Heerlen, The Netherlands. (Statistisch Jaarboek 1999. Centraal Bureau voor de Statistiek)
Landelijke Medische Registratie, LMR, Prismant, 2000.
Goettler M, Schneeweiss S, Hasford J. Adverse Drug Reaction Monitoring-Cost and Benefit Considerations Part II: Cost and Preventability of Adverse Drug Reactions Leading to Hospital Admission. Pharmacoepidemiology and Drug Safety 1997,6:79-90.
Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek, methoden en richtlijnen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen; 2000, pag. 169.
Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek, methoden en richtlijnen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen; 2000, pag. 78. [Manual for cost research, methods and guidelines for economic evaluations in health care. Amstelveen The Netherlands: Council of Health Care Insurances, 2000.]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beijer, H., de Blaey, C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24, 46–54 (2002). https://doi.org/10.1023/A:1015570104121
Issue Date:
DOI: https://doi.org/10.1023/A:1015570104121